| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/17/2023 | -4.76% | Morgan Stanley | $11 → $12 | Maintains | Equal-Weight |
| 01/13/2023 | 11.11% | Barclays | $13 → $14 | Maintains | Overweight |
| 01/10/2023 | 11.11% | Telsey Advisory Group | $12 → $14 | Maintains | Outperform |
| 11/11/2022 | -12.7% | Morgan Stanley | $9 → $11 | Maintains | Equal-Weight |
| 08/15/2022 | 11.11% | Barclays | $15 → $14 | Maintains | Overweight |
| 08/12/2022 | -28.57% | Morgan Stanley | $8 → $9 | Maintains | Equal-Weight |
| 08/12/2022 | -4.76% | Telsey Advisory Group | $9 → $12 | Maintains | Outperform |
| 08/08/2022 | -28.57% | Telsey Advisory Group | $12 → $9 | Maintains | Outperform |
| 07/20/2022 | -20.63% | Piper Sandler | $15 → $10 | Maintains | Overweight |
| 05/13/2022 | -36.51% | Morgan Stanley | $12 → $8 | Maintains | Equal-Weight |
| 04/05/2022 | -4.76% | Guggenheim | $14 → $12 | Maintains | Buy |
| 03/31/2022 | -4.76% | Telsey Advisory Group | $11 → $12 | Maintains | Outperform |
| 03/25/2022 | -12.7% | Telsey Advisory Group | $14 → $11 | Maintains | Outperform |
| 11/30/2021 | 42.86% | Barclays | → $18 | Initiates Coverage On | → Overweight |
| 11/29/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 11/29/2021 | -4.76% | Morgan Stanley | → $12 | Initiates Coverage On | → Equal-Weight |
| 11/29/2021 | 11.11% | Guggenheim | → $14 | Initiates Coverage On | → Buy |
| 11/29/2021 | 42.86% | Barclays | → $18 | Initiates Coverage On | → Overweight |
| 11/29/2021 | 26.98% | Jefferies | → $16 | Initiates Coverage On | → Buy |
| 11/29/2021 | 19.05% | B of A Securities | → $15 | Initiates Coverage On | → Buy |
| 11/29/2021 | 11.11% | Baird | → $14 | Initiates Coverage On | → Outperform |
| 11/29/2021 | 11.11% | Telsey Advisory Group | → $14 | Initiates Coverage On | → Outperform |
| 11/29/2021 | 26.98% | Piper Sandler | → $16 | Initiates Coverage On | → Overweight |
What is the target price for Arhaus (ARHS)?
The latest price target for Arhaus (NASDAQ: ARHS) was reported by Morgan Stanley on January 17, 2023. The analyst firm set a price target for $12.00 expecting ARHS to fall to within 12 months (a possible -4.76% downside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Arhaus (ARHS)?
The latest analyst rating for Arhaus (NASDAQ: ARHS) was provided by Morgan Stanley, and Arhaus maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Arhaus (ARHS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arhaus, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arhaus was filed on January 17, 2023 so you should expect the next rating to be made available sometime around January 17, 2024.
Is the Analyst Rating Arhaus (ARHS) correct?
While ratings are subjective and will change, the latest Arhaus (ARHS) rating was a maintained with a price target of $11.00 to $12.00. The current price Arhaus (ARHS) is trading at is $12.60, which is out of the analyst's predicted range.